222 related articles for article (PubMed ID: 15704197)
1. Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug-metabolizing enzymes.
Takasaki W; Yamamura M; Nozaki A; Nitanai T; Sasahara K; Itoh K; Tanaka Y
Chirality; 2005 Mar; 17(3):135-41. PubMed ID: 15704197
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective 2-hydroxylation of RS-8359, a selective and reversible MAO-A inhibitor, by cytochrome P450 in mouse and rat liver microsomes.
Itoh K; Nishiya Y; Takasaki W; Adachi M; Tanaka Y
Chirality; 2006 Aug; 18(8):592-8. PubMed ID: 16642492
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective pharmacokinetics of RS-8359, a selective and reversible inhibitor of A-type monoamine oxidase, in rats, mice, dogs, and monkeys.
Takasaki W; Yamamura M; Shigehara E; Suzuki Y; Tonohiro T; Hara T; Tanaka Y
Biol Pharm Bull; 1999 May; 22(5):498-503. PubMed ID: 10375171
[TBL] [Abstract][Full Text] [Related]
4. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.
Itoh K; Yamamura M; Takasaki W; Sasaki T; Masubuchi A; Tanaka Y
Biopharm Drug Dispos; 2006 Apr; 27(3):133-9. PubMed ID: 16400710
[TBL] [Abstract][Full Text] [Related]
5. Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol.
Itoh K; Hoshino K; Endo A; Asakawa T; Yamakami K; Noji C; Kosaka T; Tanaka Y
Chirality; 2006 Sep; 18(9):698-706. PubMed ID: 16823812
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective pharmacokinetics of flobufen in rats.
Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
[TBL] [Abstract][Full Text] [Related]
7. Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans.
Shim HJ; Kim YC; Lee JH; Park KJ; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):161-6. PubMed ID: 15803515
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective pharmacokinetics of clausenamide enantiomers and their major metabolites after single intravenous and oral administration to rats.
Zhu CJ; Zhang JT
Chirality; 2003 Oct; 15(8):668-73. PubMed ID: 12923804
[TBL] [Abstract][Full Text] [Related]
9. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Shim HJ; Kim YC; Lee JH; Kwon JW; Kim WB; Kim YG; Kim SH; Lee MG
Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256
[TBL] [Abstract][Full Text] [Related]
10. Rat strain differences in stereospecific 2-oxidation of RS-8359, a reversible and selective MAO-A inhibitor, by aldehyde oxidase.
Sasaki T; Masubuchi A; Yamamura M; Watanabe N; Hiratsuka M; Mizugaki M; Itoh K; Tanaka Y
Biopharm Drug Dispos; 2006 Jul; 27(5):247-55. PubMed ID: 16586463
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
Nakamura A; Hirota T; Sugihara K; Morino A
Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
[TBL] [Abstract][Full Text] [Related]
12. Species-related stereoselective disposition of ofloxacin in the rat, dog and monkey.
Okazaki O; Kurata T; Hakusui H; Tachizawa H
Xenobiotica; 1992 Apr; 22(4):439-50. PubMed ID: 1523865
[TBL] [Abstract][Full Text] [Related]
13. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
[TBL] [Abstract][Full Text] [Related]
14. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
15. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
16. Species-dependent stereopharmacokinetics of MK-927, a potent carbonic anhydrase inhibitor.
Lin JH; Chen IW; Lin TH
Drug Metab Dispos; 1991; 19(4):816-22. PubMed ID: 1680660
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective pharmacokinetics of tetrahydropalmatine after oral administration of (-)-enantiomer and the racemate.
Hong Z; Fan G; Chai Y; Yin X; Wu Y
Chirality; 2005 May; 17(5):293-6. PubMed ID: 15846827
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of reboxetine enantiomers in the dog.
Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
[TBL] [Abstract][Full Text] [Related]
19. Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase.
Itoh K; Yamamura M; Muramatsu S; Hoshino K; Masubuchi A; Sasaki T; Tanaka Y
Xenobiotica; 2005 Jun; 35(6):561-73. PubMed ID: 16192108
[TBL] [Abstract][Full Text] [Related]
20. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
Feng MR; Loo J; Wright J
Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
